Status:
UNKNOWN
Early Warning Value of Consumer Wearable Devices in AECOPD
Lead Sponsor:
Peking University First Hospital
Conditions:
COPD
Eligibility:
All Genders
35-80 years
Brief Summary
This is a prospective, multi-center cohort study. 150 subjects with COPD and in stable stage will be included. Wearable device's physiological parameters will be continually collected, the investigato...
Detailed Description
This is a prospective cohort study. 150 subjects aged 35～80y with stable COPD will be recruited. After enrollment, subjects wear consumer wearable devices and install APP on their mobile phones. The f...
Eligibility Criteria
Inclusion
- Patients diagnosed with stable COPD (refer to 2021 GOLD guidelines);
- Age between 35 and 80 years (both 35 and 80), either gender;
- A post-bronchodilator forced expiratory volume in 1 second percentage (FEV1%) predicted between 25%\~80%;
- Having mobile phone which can install APP of wearable device;
- Able to engage in daily activities;
Exclusion
- History of asthma, lung cancer, active pulmonary tuberculosis, bronchiectasis, diffuse lung disease (interstitial pneumonia, pulmonary sarcoidosis, occupational lung disease, sarcoidosis et al) and pleural disease;
- History of lobectomy and/or lung transplantation;
- Predicted life expectancy less than 3 years;
- History of serious underlying diseases (including severe psychiatric illnesses, mental disorders, neurological disorders, malignant tumors, chronic liver disease, heart failure, autoimmune diseases, chronic kidney disease);
- Alcoholism, drug or toxic solvents abuse;
- Moderate to severe anemia;
- Smoking or quitting smoking for less than 6 weeks;
- Skin pigmentation, deformity, arterial stenosis or occlusion of both upper limbs;
- Skin allergy to metal/plastic;
- Those who are participating in other clinical trials, cannot be followed up for a long time or have poor compliance.
Key Trial Info
Start Date :
June 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05974670
Start Date
June 21 2022
End Date
September 30 2023
Last Update
August 3 2023
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034
2
Aerospace 731 Hospital
Beijing, Beijing Municipality, China
3
Beijing Miyun Hospital
Beijing, Beijing Municipality, China
4
Civil Aviation General Hospital
Beijing, Beijing Municipality, China